img

Global Small Molecule Drug CDMO Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Small Molecule Drug CDMO Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

A CDMO is a company dedicated to providing drug development and manufacturing services for the pharmaceutical and biotechnology industries. CDMO activities can broadly be divided into four fieldsproduct development, manufacture of active pharmaceutical ingredients (API), manufacture of finished dosage forms (FDF) and pharma packaging.
Small Molecule Drug CDMO report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Small Molecule Drug CDMO market is projected to reach US$ 41580 million in 2033, increasing from US$ 27840 million in 2022, with the CAGR of 5.9% during the period of 2023 to 2033. Demand from Pharmaceutical Company and Biotechnology Company are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Small Molecule Drug CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Lonza
Catalent
Thermo Fisher Scientific
Samsung Biologics
Fareva
WuXi AppTech
WuXi Biologics
Siegfried
FUJIFILM Diosynth Biotechnologies
Asymchem
Pfizer CentreOne
Delpharm
Recipharm
AGC Pharma Chemicals
Boehringer Ingelheim
Vetter
Curia
Aenova
Porton
Segment by Type
FDF CDMO
Packaging CDMO
Clinical CDMO

Segment by Application


Pharmaceutical Company
Biotechnology Company
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Small Molecule Drug CDMO market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Small Molecule Drug CDMO introduction, etc. Small Molecule Drug CDMO Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Small Molecule Drug CDMO market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Small Molecule Drug CDMO
1.1 Small Molecule Drug CDMO Market Overview
1.1.1 Small Molecule Drug CDMO Product Scope
1.1.2 Small Molecule Drug CDMO Market Status and Outlook
1.2 Global Small Molecule Drug CDMO Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Small Molecule Drug CDMO Market Size by Region (2018-2033)
1.4 Global Small Molecule Drug CDMO Historic Market Size by Region (2018-2023)
1.5 Global Small Molecule Drug CDMO Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Small Molecule Drug CDMO Market Size (2018-2033)
1.6.1 North America Small Molecule Drug CDMO Market Size (2018-2033)
1.6.2 Europe Small Molecule Drug CDMO Market Size (2018-2033)
1.6.3 Asia-Pacific Small Molecule Drug CDMO Market Size (2018-2033)
1.6.4 Latin America Small Molecule Drug CDMO Market Size (2018-2033)
1.6.5 Middle East & Africa Small Molecule Drug CDMO Market Size (2018-2033)
2 Small Molecule Drug CDMO Market by Type
2.1 Introduction
2.1.1 FDF CDMO
2.1.2 Packaging CDMO
2.1.3 Clinical CDMO
2.2 Global Small Molecule Drug CDMO Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Small Molecule Drug CDMO Historic Market Size by Type (2018-2023)
2.2.2 Global Small Molecule Drug CDMO Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Small Molecule Drug CDMO Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Small Molecule Drug CDMO Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Small Molecule Drug CDMO Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Small Molecule Drug CDMO Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Small Molecule Drug CDMO Revenue Breakdown by Type (2018-2033)
3 Small Molecule Drug CDMO Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Company
3.1.2 Biotechnology Company
3.1.3 Other
3.2 Global Small Molecule Drug CDMO Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Small Molecule Drug CDMO Historic Market Size by Application (2018-2023)
3.2.2 Global Small Molecule Drug CDMO Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Small Molecule Drug CDMO Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Small Molecule Drug CDMO Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Small Molecule Drug CDMO Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Small Molecule Drug CDMO Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Small Molecule Drug CDMO Revenue Breakdown by Application (2018-2033)
4 Small Molecule Drug CDMO Competition Analysis by Players
4.1 Global Small Molecule Drug CDMO Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2022)
4.3 Date of Key Players Enter into Small Molecule Drug CDMO Market
4.4 Global Top Players Small Molecule Drug CDMO Headquarters and Area Served
4.5 Key Players Small Molecule Drug CDMO Product Solution and Service
4.6 Competitive Status
4.6.1 Small Molecule Drug CDMO Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Lonza
5.1.1 Lonza Profile
5.1.2 Lonza Main Business
5.1.3 Lonza Small Molecule Drug CDMO Products, Services and Solutions
5.1.4 Lonza Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.1.5 Lonza Recent Developments
5.2 Catalent
5.2.1 Catalent Profile
5.2.2 Catalent Main Business
5.2.3 Catalent Small Molecule Drug CDMO Products, Services and Solutions
5.2.4 Catalent Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.2.5 Catalent Recent Developments
5.3 Thermo Fisher Scientific
5.3.1 Thermo Fisher Scientific Profile
5.3.2 Thermo Fisher Scientific Main Business
5.3.3 Thermo Fisher Scientific Small Molecule Drug CDMO Products, Services and Solutions
5.3.4 Thermo Fisher Scientific Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.3.5 Samsung Biologics Recent Developments
5.4 Samsung Biologics
5.4.1 Samsung Biologics Profile
5.4.2 Samsung Biologics Main Business
5.4.3 Samsung Biologics Small Molecule Drug CDMO Products, Services and Solutions
5.4.4 Samsung Biologics Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.4.5 Samsung Biologics Recent Developments
5.5 Fareva
5.5.1 Fareva Profile
5.5.2 Fareva Main Business
5.5.3 Fareva Small Molecule Drug CDMO Products, Services and Solutions
5.5.4 Fareva Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.5.5 Fareva Recent Developments
5.6 WuXi AppTech
5.6.1 WuXi AppTech Profile
5.6.2 WuXi AppTech Main Business
5.6.3 WuXi AppTech Small Molecule Drug CDMO Products, Services and Solutions
5.6.4 WuXi AppTech Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.6.5 WuXi AppTech Recent Developments
5.7 WuXi Biologics
5.7.1 WuXi Biologics Profile
5.7.2 WuXi Biologics Main Business
5.7.3 WuXi Biologics Small Molecule Drug CDMO Products, Services and Solutions
5.7.4 WuXi Biologics Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.7.5 WuXi Biologics Recent Developments
5.8 Siegfried
5.8.1 Siegfried Profile
5.8.2 Siegfried Main Business
5.8.3 Siegfried Small Molecule Drug CDMO Products, Services and Solutions
5.8.4 Siegfried Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.8.5 Siegfried Recent Developments
5.9 FUJIFILM Diosynth Biotechnologies
5.9.1 FUJIFILM Diosynth Biotechnologies Profile
5.9.2 FUJIFILM Diosynth Biotechnologies Main Business
5.9.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Products, Services and Solutions
5.9.4 FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
5.10 Asymchem
5.10.1 Asymchem Profile
5.10.2 Asymchem Main Business
5.10.3 Asymchem Small Molecule Drug CDMO Products, Services and Solutions
5.10.4 Asymchem Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.10.5 Asymchem Recent Developments
5.11 Pfizer CentreOne
5.11.1 Pfizer CentreOne Profile
5.11.2 Pfizer CentreOne Main Business
5.11.3 Pfizer CentreOne Small Molecule Drug CDMO Products, Services and Solutions
5.11.4 Pfizer CentreOne Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.11.5 Pfizer CentreOne Recent Developments
5.12 Delpharm
5.12.1 Delpharm Profile
5.12.2 Delpharm Main Business
5.12.3 Delpharm Small Molecule Drug CDMO Products, Services and Solutions
5.12.4 Delpharm Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.12.5 Delpharm Recent Developments
5.13 Recipharm
5.13.1 Recipharm Profile
5.13.2 Recipharm Main Business
5.13.3 Recipharm Small Molecule Drug CDMO Products, Services and Solutions
5.13.4 Recipharm Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.13.5 Recipharm Recent Developments
5.14 AGC Pharma Chemicals
5.14.1 AGC Pharma Chemicals Profile
5.14.2 AGC Pharma Chemicals Main Business
5.14.3 AGC Pharma Chemicals Small Molecule Drug CDMO Products, Services and Solutions
5.14.4 AGC Pharma Chemicals Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.14.5 AGC Pharma Chemicals Recent Developments
5.15 Boehringer Ingelheim
5.15.1 Boehringer Ingelheim Profile
5.15.2 Boehringer Ingelheim Main Business
5.15.3 Boehringer Ingelheim Small Molecule Drug CDMO Products, Services and Solutions
5.15.4 Boehringer Ingelheim Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.15.5 Boehringer Ingelheim Recent Developments
5.16 Vetter
5.16.1 Vetter Profile
5.16.2 Vetter Main Business
5.16.3 Vetter Small Molecule Drug CDMO Products, Services and Solutions
5.16.4 Vetter Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.16.5 Vetter Recent Developments
5.17 Curia
5.17.1 Curia Profile
5.17.2 Curia Main Business
5.17.3 Curia Small Molecule Drug CDMO Products, Services and Solutions
5.17.4 Curia Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.17.5 Curia Recent Developments
5.18 Aenova
5.18.1 Aenova Profile
5.18.2 Aenova Main Business
5.18.3 Aenova Small Molecule Drug CDMO Products, Services and Solutions
5.18.4 Aenova Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.18.5 Aenova Recent Developments
5.19 Porton
5.19.1 Porton Profile
5.19.2 Porton Main Business
5.19.3 Porton Small Molecule Drug CDMO Products, Services and Solutions
5.19.4 Porton Small Molecule Drug CDMO Revenue (US$ Million) & (2018-2023)
5.19.5 Porton Recent Developments
6 North America
6.1 North America Small Molecule Drug CDMO Market Size by Country (2018-2033)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMO Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Small Molecule Drug CDMO Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Small Molecule Drug CDMO Market Dynamics
11.1 Small Molecule Drug CDMO Industry Trends
11.2 Small Molecule Drug CDMO Market Drivers
11.3 Small Molecule Drug CDMO Market Challenges
11.4 Small Molecule Drug CDMO Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Small Molecule Drug CDMO Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Small Molecule Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Small Molecule Drug CDMO Market Size Share by Region (2018-2023)
Table 4. Global Small Molecule Drug CDMO Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Small Molecule Drug CDMO Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Small Molecule Drug CDMO Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Small Molecule Drug CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Small Molecule Drug CDMO Revenue Market Share by Type (2018-2023)
Table 9. Global Small Molecule Drug CDMO Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Small Molecule Drug CDMO Revenue Market Share by Type (2024-2033)
Table 11. North America Small Molecule Drug CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Small Molecule Drug CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Small Molecule Drug CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Small Molecule Drug CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Small Molecule Drug CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Small Molecule Drug CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Small Molecule Drug CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Small Molecule Drug CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Small Molecule Drug CDMO Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Small Molecule Drug CDMO Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Small Molecule Drug CDMO Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Small Molecule Drug CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Small Molecule Drug CDMO Revenue Market Share by Application (2018-2023)
Table 24. Global Small Molecule Drug CDMO Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Small Molecule Drug CDMO Revenue Market Share by Application (2024-2033)
Table 26. North America Small Molecule Drug CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Small Molecule Drug CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Small Molecule Drug CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Small Molecule Drug CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Small Molecule Drug CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Small Molecule Drug CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Small Molecule Drug CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Small Molecule Drug CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Small Molecule Drug CDMO Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Small Molecule Drug CDMO Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Small Molecule Drug CDMO Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Small Molecule Drug CDMO Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Drug CDMO as of 2022)
Table 39. Date of Key Players Enter into Small Molecule Drug CDMO Market
Table 40. Global Small Molecule Drug CDMO Key Players Headquarters and Area Served
Table 41. Small Molecule Drug CDMO Product Solution and Service
Table 42. Global Small Molecule Drug CDMO Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Lonza Basic Information List
Table 45. Lonza Description and Business Overview
Table 46. Lonza Small Molecule Drug CDMO Products, Services and Solutions
Table 47. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Lonza (2018-2023)
Table 48. Lonza Recent Developments
Table 49. Catalent Basic Information List
Table 50. Catalent Description and Business Overview
Table 51. Catalent Small Molecule Drug CDMO Products, Services and Solutions
Table 52. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Catalent (2018-2023)
Table 53. Catalent Recent Developments
Table 54. Thermo Fisher Scientific Basic Information List
Table 55. Thermo Fisher Scientific Description and Business Overview
Table 56. Thermo Fisher Scientific Small Molecule Drug CDMO Products, Services and Solutions
Table 57. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Thermo Fisher Scientific (2018-2023)
Table 58. Thermo Fisher Scientific Recent Developments
Table 59. Samsung Biologics Basic Information List
Table 60. Samsung Biologics Description and Business Overview
Table 61. Samsung Biologics Small Molecule Drug CDMO Products, Services and Solutions
Table 62. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Samsung Biologics (2018-2023)
Table 63. Samsung Biologics Recent Developments
Table 64. Fareva Basic Information List
Table 65. Fareva Description and Business Overview
Table 66. Fareva Small Molecule Drug CDMO Products, Services and Solutions
Table 67. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Fareva (2018-2023)
Table 68. Fareva Recent Developments
Table 69. WuXi AppTech Basic Information List
Table 70. WuXi AppTech Description and Business Overview
Table 71. WuXi AppTech Small Molecule Drug CDMO Products, Services and Solutions
Table 72. Revenue (US$ Million) in Small Molecule Drug CDMO Business of WuXi AppTech (2018-2023)
Table 73. WuXi AppTech Recent Developments
Table 74. WuXi Biologics Basic Information List
Table 75. WuXi Biologics Description and Business Overview
Table 76. WuXi Biologics Small Molecule Drug CDMO Products, Services and Solutions
Table 77. Revenue (US$ Million) in Small Molecule Drug CDMO Business of WuXi Biologics (2018-2023)
Table 78. WuXi Biologics Recent Developments
Table 79. Siegfried Basic Information List
Table 80. Siegfried Description and Business Overview
Table 81. Siegfried Small Molecule Drug CDMO Products, Services and Solutions
Table 82. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Siegfried (2018-2023)
Table 83. Siegfried Recent Developments
Table 84. FUJIFILM Diosynth Biotechnologies Basic Information List
Table 85. FUJIFILM Diosynth Biotechnologies Description and Business Overview
Table 86. FUJIFILM Diosynth Biotechnologies Small Molecule Drug CDMO Products, Services and Solutions
Table 87. Revenue (US$ Million) in Small Molecule Drug CDMO Business of FUJIFILM Diosynth Biotechnologies (2018-2023)
Table 88. FUJIFILM Diosynth Biotechnologies Recent Developments
Table 89. Asymchem Basic Information List
Table 90. Asymchem Description and Business Overview
Table 91. Asymchem Small Molecule Drug CDMO Products, Services and Solutions
Table 92. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Asymchem (2018-2023)
Table 93. Asymchem Recent Developments
Table 94. Pfizer CentreOne Basic Information List
Table 95. Pfizer CentreOne Description and Business Overview
Table 96. Pfizer CentreOne Small Molecule Drug CDMO Products, Services and Solutions
Table 97. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Pfizer CentreOne (2018-2023)
Table 98. Pfizer CentreOne Recent Developments
Table 99. Delpharm Basic Information List
Table 100. Delpharm Description and Business Overview
Table 101. Delpharm Small Molecule Drug CDMO Products, Services and Solutions
Table 102. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Delpharm (2018-2023)
Table 103. Delpharm Recent Developments
Table 104. Recipharm Basic Information List
Table 105. Recipharm Description and Business Overview
Table 106. Recipharm Small Molecule Drug CDMO Products, Services and Solutions
Table 107. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Recipharm (2018-2023)
Table 108. Recipharm Recent Developments
Table 109. AGC Pharma Chemicals Basic Information List
Table 110. AGC Pharma Chemicals Description and Business Overview
Table 111. AGC Pharma Chemicals Small Molecule Drug CDMO Products, Services and Solutions
Table 112. Revenue (US$ Million) in Small Molecule Drug CDMO Business of AGC Pharma Chemicals (2018-2023)
Table 113. AGC Pharma Chemicals Recent Developments
Table 114. Boehringer Ingelheim Basic Information List
Table 115. Boehringer Ingelheim Description and Business Overview
Table 116. Boehringer Ingelheim Small Molecule Drug CDMO Products, Services and Solutions
Table 117. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Boehringer Ingelheim (2018-2023)
Table 118. Boehringer Ingelheim Recent Developments
Table 119. Vetter Basic Information List
Table 120. Vetter Description and Business Overview
Table 121. Vetter Small Molecule Drug CDMO Products, Services and Solutions
Table 122. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Vetter (2018-2023)
Table 123. Vetter Recent Developments
Table 124. Curia Basic Information List
Table 125. Curia Description and Business Overview
Table 126. Curia Small Molecule Drug CDMO Products, Services and Solutions
Table 127. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Curia (2018-2023)
Table 128. Curia Recent Developments
Table 129. Aenova Basic Information List
Table 130. Aenova Description and Business Overview
Table 131. Aenova Small Molecule Drug CDMO Products, Services and Solutions
Table 132. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Aenova (2018-2023)
Table 133. Aenova Recent Developments
Table 134. Porton Basic Information List
Table 135. Porton Description and Business Overview
Table 136. Porton Small Molecule Drug CDMO Products, Services and Solutions
Table 137. Revenue (US$ Million) in Small Molecule Drug CDMO Business of Porton (2018-2023)
Table 138. Porton Recent Developments
Table 139. North America Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 140. North America Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 141. Europe Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 142. Europe Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 143. Asia-Pacific Small Molecule Drug CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 144. Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 145. Asia-Pacific Small Molecule Drug CDMO Market Size by Region (2024-2033) & (US$ Million)
Table 146. Asia-Pacific Small Molecule Drug CDMO Market Share by Region (2018-2023)
Table 147. Asia-Pacific Small Molecule Drug CDMO Market Share by Region (2024-2033)
Table 148. Latin America Small Molecule Drug CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 149. Latin America Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 150. Latin America Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 151. Middle East & Africa Small Molecule Drug CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 152. Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 153. Middle East & Africa Small Molecule Drug CDMO Market Size by Country (2024-2033) & (US$ Million)
Table 154. Small Molecule Drug CDMO Market Trends
Table 155. Small Molecule Drug CDMO Market Drivers
Table 156. Small Molecule Drug CDMO Market Challenges
Table 157. Small Molecule Drug CDMO Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Small Molecule Drug CDMO Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Small Molecule Drug CDMO Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Small Molecule Drug CDMO Market Share by Regions: 2022 VS 2033
Figure 4. Global Small Molecule Drug CDMO Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Small Molecule Drug CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Small Molecule Drug CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Small Molecule Drug CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Small Molecule Drug CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Small Molecule Drug CDMO Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of FDF CDMO
Figure 11. Global FDF CDMO Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Packaging CDMO
Figure 13. Global Packaging CDMO Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Clinical CDMO
Figure 15. Global Clinical CDMO Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global Small Molecule Drug CDMO Market Size Share by Type: 2022 & 2033
Figure 17. North America Small Molecule Drug CDMO Revenue Market Share by Type (2018-2033)
Figure 18. Europe Small Molecule Drug CDMO Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific Small Molecule Drug CDMO Revenue Market Share by Type (2018-2033)
Figure 20. Latin America Small Molecule Drug CDMO Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa Small Molecule Drug CDMO Revenue Market Share by Type (2018-2033)
Figure 22. Pharmaceutical Company Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Biotechnology Company Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Global Small Molecule Drug CDMO Market Size Share by Application: 2022 & 2033
Figure 26. North America Small Molecule Drug CDMO Revenue Market Share by Application (2018-2033)
Figure 27. Europe Small Molecule Drug CDMO Revenue Market Share by Application (2018-2033)
Figure 28. Asia-Pacific Small Molecule Drug CDMO Revenue Market Share by Application (2018-2033)
Figure 29. Latin America Small Molecule Drug CDMO Revenue Market Share by Application (2018-2033)
Figure 30. Middle East and Africa Small Molecule Drug CDMO Revenue Market Share by Application (2018-2033)
Figure 31. Small Molecule Drug CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 32. Global Top 5 and Top 10 Players Small Molecule Drug CDMO Market Share in 2022
Figure 33. North America Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 34. United States Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 35. Canada Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 36. Germany Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 37. France Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 38. U.K. Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 39. Italy Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 40. Russia Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 41. Nordic Countries Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 42. Asia-Pacific Small Molecule Drug CDMO Market Share by Region (2018-2033)
Figure 43. China Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 44. Japan Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 45. South Korea Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 46. Southeast Asia Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 47. India Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 48. Australia Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 49. Latin America Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 50. Mexico Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 51. Brazil Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 52. Middle East & Africa Small Molecule Drug CDMO Market Share by Country (2018-2033)
Figure 53. Turkey Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 55. UAE Small Molecule Drug CDMO Market Size (2018-2033) & (US$ Million)
Figure 56. Bottom-up and Top-down Approaches for This Report